scispace - formally typeset
A

Avi Eldar

Researcher at Hebrew University of Jerusalem

Publications -  39
Citations -  3941

Avi Eldar is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Streptococcus iniae & Lactococcus garvieae. The author has an hindex of 29, co-authored 34 publications receiving 3568 citations. Previous affiliations of Avi Eldar include University of California, Davis.

Papers
More filters
Journal ArticleDOI

A Herpesvirus Associated with Mass Mortality of Juvenile and Adult Koi, a Strain of Common Carp

TL;DR: It is strongly suspect that this newly recognized koi herpesvirus (KHV) has the potential to be a significant cause of mortality among koi and presumably common carp.
Journal ArticleDOI

Genome sequences of three koi herpesvirus isolates representing the expanding distribution of an emerging disease threatening koi and common carp worldwide

TL;DR: The conclusion that at least some of these mutations occurred in vivo prompts the hypothesis that loss of gene functions might be associated with emergence of the disease and provides a basis for further investigations into the molecular epidemiology of the virus.
Journal ArticleDOI

Identification of a Novel RNA Virus Lethal to Tilapia

TL;DR: The cohabitation of healthy and diseased fish demonstrated that the disease is contagious and that mortalities occur within a few days, suggesting the mounting of a protective immune response.
Journal ArticleDOI

Initial characteristics of koi herpesvirus and development of a polymerase chain reaction assay to detect the virus in koi, Cyprinus carpio koi

TL;DR: Initial characteristics of the virus show that it is clearly different from Herpesvirus cyprini (CHV), the most commonly known herpesvirus from cyprinid fish, and the genomic DNA restriction fragments clearly distinguish KHV from CHV and CCV.
Journal ArticleDOI

Characterization of a Novel Orthomyxo-like Virus Causing Mass Die-Offs of Tilapia

TL;DR: Characterization of the causative agent as a novel orthomyxo-like virus, tilapia lake virus (TiLV), and complete genomic and protein sequences that will facilitate TiLV detection and containment and enable vaccine development are reported.